Universe Pharmaceuticals annual current ratio
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Current Ratio Growth & History (UPC)
Universe Pharmaceuticals's current ratio was 4.07 for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 4.07 | 1.53 | +60.06% |
| 2024 | 2024-09-30 | 2.54 | 0.70 | +38.37% |
| 2023 | 2023-09-30 | 1.84 | −1.33 | −42.02% |
| 2022 | 2022-09-30 | 3.17 | −1.33 | −29.63% |
| 2021 | 2021-09-30 | 4.50 | 1.59 | +54.77% |
| 2020 | 2020-09-30 | 2.91 | — | — |
Universe Pharmaceuticals quarterly current ratio
Q4.20
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-03-31 | 4.05 | 1.27 | +45.69% |
| Q4 2025 | 2025-09-30 | 4.07 | 1.53 | +60.06% |
| Q2 2025 | 2025-03-31 | 2.78 | 1.15 | +70.69% |
| Q4 2024 | 2024-09-30 | 2.54 | 0.70 | +38.37% |
| Q2 2024 | 2024-03-31 | 1.63 | −0.63 | −28.00% |
| Q4 2023 | 2023-09-30 | 1.84 | −1.33 | −42.02% |
| Q2 2023 | 2023-03-31 | 2.26 | −2.80 | −55.35% |
| Q4 2022 | 2022-09-30 | 3.17 | −1.33 | −29.63% |
| Q2 2022 | 2022-03-31 | 5.06 | — | — |
| Q4 2021 | 2021-09-30 | 4.50 | 1.59 | +54.77% |
| Q4 2020 | 2020-09-30 | 2.91 | — | — |
Universe Pharmaceuticals current ratio trends
Over the last five fiscal years, Universe Pharmaceuticals's current ratio increased from 2.91 to 4.07, a change of 1.16. The latest reported quarter, Q2 2026, shows 4.05.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗